Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Research

Evaluation of clinical and laboratory characteristics of dengue viral infection and risk factors of dengue hemorrhagic fever: a multi-center retrospective analysis

Authors: Muhammad Riaz, Sabriah Noor Binti Harun, Tauqeer Hussain Mallhi, Yusra Habib Khan, Muhammad Hammad Butt, Aamir Husain, Muhammad Mujeeb khan, Amer Hayat Khan

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Dengue Viral Infection (DVI) has become endemic in Pakistan since the first major outbreak in Karachi in 1996. Despite aggressive measures taken by relevant authorities, Pakistan has been dealing with a worsening dengue crisis for the past two decades. DHF is severe form of dengue infection which is linked with significant morbidity and mortality. Early identification of severe dengue infections can reduce the morbidity and mortality. In this context we planned current study in which we find out the different factors related with DHF as well as clinical laboratory features of DHF and compare them to DF so that patients can be best evaluated for DHF and managed accordingly at admission.

Methods

Retrospective study conducted over a period of 6 years (2013–2018) in two tertiary care hospitals in Pakistan. Data were collected by using a pre-structured data collection form. Data were statistically analyzed to determine the clinical and laboratory characteristics of DVI and risk factors of dengue hemorrhagic fever (DHF).

Results

A total 512 dengue cases (34.05 ± 15.08 years; Male 69.53%) were reviewed. Most common clinical manifestations of DVI were fever (99.60%), headache (89.1%), chills (86.5%), rigors (86.5%), myalgia (72.3%). Less common clinical manifestations were vomiting (52.5%), arthralgia (50.2%) and skin rashes (47.5%). Furthermore, nasal bleeding (44.1%), gum bleeding (32.6%), pleural effusion (13.9%) and hematuria (13.1%) were more profound clinical presentations among DHF patients. Mortality rate was 1.5% in this study. Logistic regression analysis indicated that delayed hospitalization (OR: 2.30) and diabetes mellitus (OR:2.71), shortness of breath (OR:2.21), association with risk groups i.e., living near stagnant water, travelling to endemic areas, living in endemic regions (OR:1.95), and presence of warning signs (OR:2.18) were identified as risk factors of DHF. Statistically we found that there is strong association of diabetes mellitus (DM) with DHF while the patient suffering from DM individually had higher odds (2.71) of developing DHF than patients without disease.

Conclusions

The current study demonstrated that the clinical and laboratory profiles of DF and DHF are significantly distinct. Significant predictors of DHF were advanced age, diabetes mellitus, ascites, pleural effusion, thick gallbladder and delayed hospitalization. The identification of these factors at early stage provides opportunities for the clinicians to identify high risk patients and to reduce dengue-related morbidity and mortality.
Literature
2.
go back to reference Atapattu KV, Salibi G, Tzenios N. A study on the relationship between the rainy season and dengue outbreak in the Colombo District of Sri Lanka. Special J Med Acad Other Life Sci. 2023;1(3):1–25. Atapattu KV, Salibi G, Tzenios N. A study on the relationship between the rainy season and dengue outbreak in the Colombo District of Sri Lanka. Special J Med Acad Other Life Sci. 2023;1(3):1–25.
3.
go back to reference Khattak A, et al. Burden and distribution of dengue infection in Pakistan (2000-19): a review. Braz J Biol. 2023;84:e267982.PubMedCrossRef Khattak A, et al. Burden and distribution of dengue infection in Pakistan (2000-19): a review. Braz J Biol. 2023;84:e267982.PubMedCrossRef
4.
go back to reference Khalil MAM, et al. Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan. BMC Res Notes. 2014;7:1–7.CrossRef Khalil MAM, et al. Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan. BMC Res Notes. 2014;7:1–7.CrossRef
5.
go back to reference Fayzan M, et al. Current knowledge and awareness of dengue fever among students of government college university Faisalabad. J ISSN. 2022;2766:2276. Fayzan M, et al. Current knowledge and awareness of dengue fever among students of government college university Faisalabad. J ISSN. 2022;2766:2276.
6.
go back to reference Silva NM, Santos NC, Martins IC. Dengue and Zika viruses: epidemiological history, potential therapies, and promising vaccines. Trop Med Infect Dis. 2020;5(4):150.PubMedPubMedCentralCrossRef Silva NM, Santos NC, Martins IC. Dengue and Zika viruses: epidemiological history, potential therapies, and promising vaccines. Trop Med Infect Dis. 2020;5(4):150.PubMedPubMedCentralCrossRef
7.
go back to reference Khan E, et al. Demographic and clinical features of dengue fever in Pakistan from 2003–2007: a retrospective cross-sectional study. PLoS One. 2010;5(9):e12505.PubMedPubMedCentralCrossRef Khan E, et al. Demographic and clinical features of dengue fever in Pakistan from 2003–2007: a retrospective cross-sectional study. PLoS One. 2010;5(9):e12505.PubMedPubMedCentralCrossRef
8.
9.
go back to reference Mangold KA, Reynolds SL. A review of dengue fever: a resurging tropical disease. Pediatr Emerg Care. 2013;29(5):665–9.PubMedCrossRef Mangold KA, Reynolds SL. A review of dengue fever: a resurging tropical disease. Pediatr Emerg Care. 2013;29(5):665–9.PubMedCrossRef
10.
go back to reference Haider Z, et al. Dengue fever in Pakistan: a paradigm shift; changing epidemiology and clinical patterns. Perspect Public Health. 2015;135(6):294–8.PubMedCrossRef Haider Z, et al. Dengue fever in Pakistan: a paradigm shift; changing epidemiology and clinical patterns. Perspect Public Health. 2015;135(6):294–8.PubMedCrossRef
12.
go back to reference Haroon M, et al. Dengue outbreak in Peshawar: clinical features and laboratory markers of dengue virus infection. J Infect Public Health. 2019;12(2):258–62.PubMedCrossRef Haroon M, et al. Dengue outbreak in Peshawar: clinical features and laboratory markers of dengue virus infection. J Infect Public Health. 2019;12(2):258–62.PubMedCrossRef
13.
go back to reference Gul N, et al. Epidemiological parameters of dengue infections in Pakistan. Pak J Med Health Sci. 2023;17(02):296–296. Gul N, et al. Epidemiological parameters of dengue infections in Pakistan. Pak J Med Health Sci. 2023;17(02):296–296.
14.
go back to reference Khan E, et al. The clinical features of co-circulating dengue viruses and the absence of dengue hemorrhagic fever in Pakistan. Front Public Health. 2020;8:287.PubMedPubMedCentralCrossRef Khan E, et al. The clinical features of co-circulating dengue viruses and the absence of dengue hemorrhagic fever in Pakistan. Front Public Health. 2020;8:287.PubMedPubMedCentralCrossRef
15.
16.
go back to reference Wayez A, et al. Study of platelet indices in dengue fever with thrombocytopenia and correlation of immature platelet fraction (IPF) with platelet recovery. Arch Hematol Res Artic Rev. 2020;5(1):001–5. Wayez A, et al. Study of platelet indices in dengue fever with thrombocytopenia and correlation of immature platelet fraction (IPF) with platelet recovery. Arch Hematol Res Artic Rev. 2020;5(1):001–5.
17.
go back to reference Organization WH. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. 2011. Organization WH. Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever. 2011.
18.
go back to reference Khalil MA, et al. Acute kidney injury in dengue virus infection. Nephrol Dial Transplant Plus. 2012;5(5):390–4. Khalil MA, et al. Acute kidney injury in dengue virus infection. Nephrol Dial Transplant Plus. 2012;5(5):390–4.
19.
go back to reference Wichmann O, et al. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health. 2004;9:1022–9.PubMedCrossRef Wichmann O, et al. Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand. Trop Med Int Health. 2004;9:1022–9.PubMedCrossRef
20.
go back to reference Yusra Habib K, et al. Management of emergent complications associated with end stage renal disease. 2015. Yusra Habib K, et al. Management of emergent complications associated with end stage renal disease. 2015.
21.
go back to reference Mallhi TH, et al. Incidence, characteristics and risk factors of acute kidney injury among dengue patients: a retrospective analysis. PLoS One. 2015;10(9):e0138465.PubMedPubMedCentralCrossRef Mallhi TH, et al. Incidence, characteristics and risk factors of acute kidney injury among dengue patients: a retrospective analysis. PLoS One. 2015;10(9):e0138465.PubMedPubMedCentralCrossRef
22.
go back to reference Mallhi TH, et al. Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study. BMC Infect Dis. 2015;15(1):1–12.CrossRef Mallhi TH, et al. Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study. BMC Infect Dis. 2015;15(1):1–12.CrossRef
23.
go back to reference Aamir M, Masood G, Aamir W. Gender difference in patients with dengue fever admitted in a teaching hospital, Lahore. Cell. 2014;92(8):1. Aamir M, Masood G, Aamir W. Gender difference in patients with dengue fever admitted in a teaching hospital, Lahore. Cell. 2014;92(8):1.
24.
go back to reference Anwar F, et al. Dengue virus epidemics: a recent report of 2017 from district Mardan, Khyber Pakhtunkhwa province, Pakistan. Int J Mosq Res. 2019;6(1):46–9. Anwar F, et al. Dengue virus epidemics: a recent report of 2017 from district Mardan, Khyber Pakhtunkhwa province, Pakistan. Int J Mosq Res. 2019;6(1):46–9.
25.
go back to reference Anker M, Arima Y. Male–female differences in the number of reported incident dengue fever cases in six Asian countries. Western Pac Surveill Response J. 2011;2(2):17.PubMedPubMedCentral Anker M, Arima Y. Male–female differences in the number of reported incident dengue fever cases in six Asian countries. Western Pac Surveill Response J. 2011;2(2):17.PubMedPubMedCentral
27.
go back to reference Rehman AU, et al. Incidence of dengue fever, serotypes, clinical features, and laboratory markers: a case study of 2019 outbreak at district Shangla, KP, Pakistan. Afr Health Sci. 2022;22(1):521–31.PubMedPubMedCentralCrossRef Rehman AU, et al. Incidence of dengue fever, serotypes, clinical features, and laboratory markers: a case study of 2019 outbreak at district Shangla, KP, Pakistan. Afr Health Sci. 2022;22(1):521–31.PubMedPubMedCentralCrossRef
29.
go back to reference Hasan MJ, et al. Comparison of clinical manifestation of dengue fever in Bangladesh: an observation over a decade. BMC Infect Dis. 2021;21:1–10.CrossRef Hasan MJ, et al. Comparison of clinical manifestation of dengue fever in Bangladesh: an observation over a decade. BMC Infect Dis. 2021;21:1–10.CrossRef
30.
go back to reference Dissanayake S, et al. Vitamin D deficiency in dengue hemorrhagic fever and dengue shock syndrome among Sri Lankan children: a case-control study. J Trop Med. 2021;2021:4173303.PubMedPubMedCentralCrossRef Dissanayake S, et al. Vitamin D deficiency in dengue hemorrhagic fever and dengue shock syndrome among Sri Lankan children: a case-control study. J Trop Med. 2021;2021:4173303.PubMedPubMedCentralCrossRef
31.
go back to reference Mallhi TH, et al. Determinants of mortality and prolonged hospital stay among dengue patients attending tertiary care hospital: a cross-sectional retrospective analysis. BMJ Open. 2017;7(7):e016805.PubMedPubMedCentralCrossRef Mallhi TH, et al. Determinants of mortality and prolonged hospital stay among dengue patients attending tertiary care hospital: a cross-sectional retrospective analysis. BMJ Open. 2017;7(7):e016805.PubMedPubMedCentralCrossRef
32.
go back to reference Rathore AP, Farouk FS, John ALS. Risk factors and biomarkers of severe dengue. Curr Opin Virol. 2020;43:1–8.PubMedCrossRef Rathore AP, Farouk FS, John ALS. Risk factors and biomarkers of severe dengue. Curr Opin Virol. 2020;43:1–8.PubMedCrossRef
33.
go back to reference Htun TP, Xiong Z, Pang J. Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis. Emerg Microbes Infect. 2021;10:1116–28.PubMedPubMedCentralCrossRef Htun TP, Xiong Z, Pang J. Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis. Emerg Microbes Infect. 2021;10:1116–28.PubMedPubMedCentralCrossRef
34.
go back to reference Chan K-S, et al. Effect of serotypes on clinical manifestations of dengue fever in adults. J Microbiol Immunol Infect. 2009;42(6):471–8.PubMed Chan K-S, et al. Effect of serotypes on clinical manifestations of dengue fever in adults. J Microbiol Immunol Infect. 2009;42(6):471–8.PubMed
35.
go back to reference Patel GR, et al. Coagulation abnormalities and their relationship with bleeding manifestations in patients with dengue-A single center observational study. Asian Pac J Trop Med. 2023;16(2):65–71.CrossRef Patel GR, et al. Coagulation abnormalities and their relationship with bleeding manifestations in patients with dengue-A single center observational study. Asian Pac J Trop Med. 2023;16(2):65–71.CrossRef
36.
go back to reference Wills BA, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35(3):277–85.PubMedCrossRef Wills BA, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002;35(3):277–85.PubMedCrossRef
37.
go back to reference Adane T, Getawa S. Coagulation abnormalities in dengue fever infection: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;15(8):e0009666.PubMedPubMedCentralCrossRef Adane T, Getawa S. Coagulation abnormalities in dengue fever infection: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;15(8):e0009666.PubMedPubMedCentralCrossRef
38.
go back to reference Irshad Z, et al. Association of abnormal coagulation tests in dengue fever with clinical outcomes of the patients. Pak Armed Forces Med J. 2022;72(1):159–63.CrossRef Irshad Z, et al. Association of abnormal coagulation tests in dengue fever with clinical outcomes of the patients. Pak Armed Forces Med J. 2022;72(1):159–63.CrossRef
39.
go back to reference Prattay KMR, et al. A retrospective study on the socio-demographic factors and clinical parameters of dengue disease and their effects on the clinical course and recovery of the patients in a tertiary care hospital of Bangladesh. PLoS Negl Trop Dis. 2022;16(4):e0010297.PubMedPubMedCentralCrossRef Prattay KMR, et al. A retrospective study on the socio-demographic factors and clinical parameters of dengue disease and their effects on the clinical course and recovery of the patients in a tertiary care hospital of Bangladesh. PLoS Negl Trop Dis. 2022;16(4):e0010297.PubMedPubMedCentralCrossRef
40.
go back to reference Elian E, Assagaf H. Warning sign as prognostic value for pediatric dengue hemorrhagic fever. Ann Rom Soc Cell Biol. 2021;25(6):17837–42. Elian E, Assagaf H. Warning sign as prognostic value for pediatric dengue hemorrhagic fever. Ann Rom Soc Cell Biol. 2021;25(6):17837–42.
41.
go back to reference Kurniawan A, Rahmat R, Kartapraja RD. Dengue fever with warning sign (case report). J Innov Res Knowl. 2023;2(11):4315–24.CrossRef Kurniawan A, Rahmat R, Kartapraja RD. Dengue fever with warning sign (case report). J Innov Res Knowl. 2023;2(11):4315–24.CrossRef
42.
go back to reference Mahmood S, et al. Does comorbidity increase the risk of dengue hemorrhagic fever and dengue shock syndrome? Int Sch Res Notices. 2013;2013:1–5. Mahmood S, et al. Does comorbidity increase the risk of dengue hemorrhagic fever and dengue shock syndrome? Int Sch Res Notices. 2013;2013:1–5.
43.
go back to reference Goh P. Dengue perimyocarditis: a case report. Hong Kong J Emerg Med. 2010;17(1):58–60.CrossRef Goh P. Dengue perimyocarditis: a case report. Hong Kong J Emerg Med. 2010;17(1):58–60.CrossRef
44.
go back to reference Huang C-C, et al. Dengue fever mortality score: a novel decision rule to predict death from dengue fever. J Infect. 2017;75(6):532–40.PubMedCrossRef Huang C-C, et al. Dengue fever mortality score: a novel decision rule to predict death from dengue fever. J Infect. 2017;75(6):532–40.PubMedCrossRef
46.
go back to reference Le Gonidec E, et al. Clinical survey of dengue virus circulation in the Republic of Djibouti between 2011 and 2014 identifies serotype 3 epidemic and recommends clinical diagnosis guidelines for resource limited settings. PLoS Negl Trop Dis. 2016;10(6):e0004755.PubMedPubMedCentralCrossRef Le Gonidec E, et al. Clinical survey of dengue virus circulation in the Republic of Djibouti between 2011 and 2014 identifies serotype 3 epidemic and recommends clinical diagnosis guidelines for resource limited settings. PLoS Negl Trop Dis. 2016;10(6):e0004755.PubMedPubMedCentralCrossRef
47.
go back to reference Shah H, Pandey B. Risk factors of adult dengue fever in urban community of Nepal. Glob J Infect Dis Clin Res. 2021;7:64–9. Shah H, Pandey B. Risk factors of adult dengue fever in urban community of Nepal. Glob J Infect Dis Clin Res. 2021;7:64–9.
48.
go back to reference Ali S, et al. Dengue outbreaks in Khyber Pakhtunkhwa (KPK), Pakistan in 2017: an integrated disease surveillance and response system (IDSRS)-based report. Pol J Microbiol. 2019;68(1):115–9.PubMedPubMedCentralCrossRef Ali S, et al. Dengue outbreaks in Khyber Pakhtunkhwa (KPK), Pakistan in 2017: an integrated disease surveillance and response system (IDSRS)-based report. Pol J Microbiol. 2019;68(1):115–9.PubMedPubMedCentralCrossRef
49.
go back to reference Khan J, Khan A. Incidence of dengue in 2013: dengue outbreak in District Swat, Khyber Pakhtunkhwa, Pakistan. Inter J Fauna Biolo Stud. 2015;2(1):1–7. Khan J, Khan A. Incidence of dengue in 2013: dengue outbreak in District Swat, Khyber Pakhtunkhwa, Pakistan. Inter J Fauna Biolo Stud. 2015;2(1):1–7.
50.
go back to reference Suleman M, et al. Dengue virus serotypes circulating in Khyber Pakhtunkhwa province, Pakistan, 2013–2015. Ann Lab Med. 2017;37(2):151.PubMedCrossRef Suleman M, et al. Dengue virus serotypes circulating in Khyber Pakhtunkhwa province, Pakistan, 2013–2015. Ann Lab Med. 2017;37(2):151.PubMedCrossRef
51.
go back to reference Teerasarntipan T, et al. Acute liver failure and death predictors in patients with dengue-induced severe hepatitis. World J Gastroenterol. 2020;26(33): 4983.PubMedPubMedCentralCrossRef Teerasarntipan T, et al. Acute liver failure and death predictors in patients with dengue-induced severe hepatitis. World J Gastroenterol. 2020;26(33): 4983.PubMedPubMedCentralCrossRef
52.
go back to reference Leowattana W, Leowattana T. Dengue hemorrhagic fever and the liver World. J Hepatol. 2021;13(12):1968. Leowattana W, Leowattana T. Dengue hemorrhagic fever and the liver World. J Hepatol. 2021;13(12):1968.
53.
go back to reference Suganthan N, Sakthilingham G, Kumanan T. Dengue fever complicated with acute liver failure: a case report of expanded dengue syndrome and literature review. SAGE Open Med Case Rep. 2020;8:2050313X20913428.PubMedPubMedCentral Suganthan N, Sakthilingham G, Kumanan T. Dengue fever complicated with acute liver failure: a case report of expanded dengue syndrome and literature review. SAGE Open Med Case Rep. 2020;8:2050313X20913428.PubMedPubMedCentral
54.
go back to reference Witayathawornwong P. DHF in infants, late infants and older children: a comparative study. Southeast Asian J Trop Med Public Health. 2005;36(4):896.PubMed Witayathawornwong P. DHF in infants, late infants and older children: a comparative study. Southeast Asian J Trop Med Public Health. 2005;36(4):896.PubMed
55.
go back to reference Kulkarni AV, et al. Spectrum, manifestations and outcomes of dengue infection in individuals with and without liver disease. J Clin Transl Hepatol. 2019;7(2):106.PubMedPubMedCentral Kulkarni AV, et al. Spectrum, manifestations and outcomes of dengue infection in individuals with and without liver disease. J Clin Transl Hepatol. 2019;7(2):106.PubMedPubMedCentral
56.
go back to reference Chang K, et al. Differences in mortality and clinical manifestations of dengue hemorrhagic fever in Taiwan in different years: a comparison for cases in 2014 and 2015 epidemics. Am J Trop Med Hyg. 2017;97(2):361.PubMedPubMedCentralCrossRef Chang K, et al. Differences in mortality and clinical manifestations of dengue hemorrhagic fever in Taiwan in different years: a comparison for cases in 2014 and 2015 epidemics. Am J Trop Med Hyg. 2017;97(2):361.PubMedPubMedCentralCrossRef
57.
go back to reference Medagama A, et al. Risk factors associated with fatal dengue hemorrhagic fever in adults: a case control study. Can J Infect Dis Med Microbiol. 2020;2020:1042976.PubMedPubMedCentralCrossRef Medagama A, et al. Risk factors associated with fatal dengue hemorrhagic fever in adults: a case control study. Can J Infect Dis Med Microbiol. 2020;2020:1042976.PubMedPubMedCentralCrossRef
58.
go back to reference Ong A, et al. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis. 2007;11(3):263–7.PubMedCrossRef Ong A, et al. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis. 2007;11(3):263–7.PubMedCrossRef
Metadata
Title
Evaluation of clinical and laboratory characteristics of dengue viral infection and risk factors of dengue hemorrhagic fever: a multi-center retrospective analysis
Authors
Muhammad Riaz
Sabriah Noor Binti Harun
Tauqeer Hussain Mallhi
Yusra Habib Khan
Muhammad Hammad Butt
Aamir Husain
Muhammad Mujeeb khan
Amer Hayat Khan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09384-z

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine